Compare AXGN & PWP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AXGN | PWP |
|---|---|---|
| Founded | N/A | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.2B |
| IPO Year | N/A | N/A |
| Metric | AXGN | PWP |
|---|---|---|
| Price | $31.59 | $19.52 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 9 | 3 |
| Target Price | ★ $33.67 | $22.33 |
| AVG Volume (30 Days) | 770.0K | ★ 830.4K |
| Earning Date | 02-24-2026 | 02-06-2026 |
| Dividend Yield | N/A | ★ 1.49% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.70 |
| Revenue | $214,709,000.00 | ★ $757,415,000.00 |
| Revenue This Year | $21.60 | N/A |
| Revenue Next Year | $15.83 | $38.06 |
| P/E Ratio | ★ N/A | $27.12 |
| Revenue Growth | ★ 18.72 | N/A |
| 52 Week Low | $9.22 | $14.12 |
| 52 Week High | $34.71 | $27.03 |
| Indicator | AXGN | PWP |
|---|---|---|
| Relative Strength Index (RSI) | 52.68 | 63.75 |
| Support Level | $30.32 | $18.20 |
| Resistance Level | $34.71 | $17.86 |
| Average True Range (ATR) | 1.50 | 0.65 |
| MACD | -0.27 | 0.23 |
| Stochastic Oscillator | 29.42 | 97.94 |
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.
Perella Weinberg Partners is an independent advisory firm that provides strategic and financial advice to a wide range of clients. The Company's activities as an investment banking advisory firm constitute a single business segment that provides a range of advisory services, including advice related to strategic and financial decisions, mergers and acquisitions execution, shareholder and defense advisory, financing and capital solutions advice with resources focused on restructuring and liability management, capital markets advisory, private capital placement, as well as specialized underwriting and research services for the energy and related industries.